Oramed Pharmaceuticals (ORMP)
Develops oral formulations for insulin and other therapeutic proteins.
$4.71
vs last close−0.04 (−0.84%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 40.52% | 16.86M shares | |
|---|---|---|---|
| 86 holders · as of Jun 30, 2026 | |||
| Insiders | 8.47% | 3.52M shares | |
| 8 holders · as of Jul 2, 2026 | |||
| Other | 51.01% | 21.22M shares | |
| remainder | |||
41.60M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
86 holders · 16.86M shares · 30 new positions · 51 increased · 19 reduced · 9 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mercer Global Advisors Inc /Adv | 3.81M | 9.16% | +1.90M | Aug 19, 2026 |
| Aquamarine Financial (Cayman) Ltd | 2.51M | 6.04% | +399.9K | Aug 12, 2026 |
| Gem Investment Advisors, LLC | 2.00M | 4.81% | +358.7K | Aug 11, 2026 |
| BlackRock, Inc. | 1.61M | 3.87% | +1.52M | Aug 7, 2026 |
| Murchinson Ltd. | 1.29M | 3.10% | −25.0K | Aug 14, 2026 |
| BML Capital Management, LLC | 866.3K | 2.08% | −2.30M | Aug 7, 2026 |
| Boothbay Fund Management, LLC | 578.6K | 1.39% | −22.1K | Aug 14, 2026 |
| Geode Capital Management, LLC | 500.7K | 1.20% | +476.4K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nadav Kidron | 7.60% | 3.12M | 13D | Aug 28, 2025 |
| Aquamarine Financial (Cayman) Ltd | 5.06% | 2.05M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 1, 2026 | Avraham Gabayofficer: Chief Financial Officer | Sale | 73,360 | $4.51 | 671,785 |
| Jul 1, 2026 | Joshua Hexterofficer: COO & CBO | Sale | 137,000 | $4.46 | 1,023,384 |
House and Senate disclosures
Not reported.